BRIEF-Salix announces filing acceptance for PLENVU® next generation bowel cleansing preparation for colonoscopies
* Salix announces filing acceptance for Plenvu®* next generation bowel cleansing preparation for colonoscopies
March 1 Sygnis AG:
* David Roth appointed Chief Financial Officer (CFO)
* Pilar de la Huerta continues to serve as co-CEO and is appointed chief business development officer (CBDO) Source text for Eikon: Further company coverage: (Gdynia Newsroom)
NEW YORK, June 28 More than a third of investors voting at Mylan NV annual meeting last week cast votes against Chairman Robert Coury's re-election as the generic drugmaker faced a shareholder campaign against its directors and executive pay packages.